Mark Leschly, 10% Owner at Cara Therapeutics, Inc. (CARA), bought 2,668,057 shares at $11.00 ($2.5M) on 2014-02-05, disclosed to the SEC on 2014-02-05.
Open-market purchase of $2.5M CARA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,442,239 | $0 | 0.0% |
| 2 | $11.00 | 225,818 | $2.5M | 100.0% |
| Total | $0.93 avg | 2,668,057 | $2.5M | 100% |
| Filing → |
| BFLY | BUY | 2012-11-15 | $299K | — | Filing → |
| ANAC | BUY | 2010-12-01 | $12.0M | — | Filing → |
| AVNC | BUY | 2007-04-16 | $2.8M | — | Filing → |